Bioactive Food Peptides in Health and Disease 2013
DOI: 10.5772/51263
|View full text |Cite
|
Sign up to set email alerts
|

Snake Venom Peptides: Promising Molecules with Anti-Tumor Effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 106 publications
0
6
0
2
Order By: Relevance
“…Dimeric peptides are peptides with two subunits that are linked covalently with a disulfide bond (Sarray et al, 2013) and peptide dimerization is currently being investigated as a potential way to increase the activity of certain peptide toxins (Vizzavona et al, 2009). Except for snake venoms (Osipov et al, 2008), a dimeric scaffold in peptides is quite rare in venomous animals, although it has occasionally been reported in the venoms of some scorpions (Zamudio et al, 1997), spiders (Santos et al, 1992) and marine cone snails (Loughnan et al, 2006).…”
Section: Dimeric Peptidesmentioning
confidence: 98%
“…Dimeric peptides are peptides with two subunits that are linked covalently with a disulfide bond (Sarray et al, 2013) and peptide dimerization is currently being investigated as a potential way to increase the activity of certain peptide toxins (Vizzavona et al, 2009). Except for snake venoms (Osipov et al, 2008), a dimeric scaffold in peptides is quite rare in venomous animals, although it has occasionally been reported in the venoms of some scorpions (Zamudio et al, 1997), spiders (Santos et al, 1992) and marine cone snails (Loughnan et al, 2006).…”
Section: Dimeric Peptidesmentioning
confidence: 98%
“…On the other hand, this diversity opens an ample scope for the use of specific inhibitors and with fewer side effects, differently from most current anticancer therapies (radiotherapy, chemotherapy) that are not specific and target both tumor and healthy cells. Thus, in recent years, new treatments tend to focus on the specific tumor microenvironment and particularly on the inhibition of tumor angiogenesis [ 144 ]. Although, disintegrins are highly effective in binding and inhibiting integrin function, which draws attention to its therapeutic potential, most clinical studies have not progressed beyond early clinical development due to the problems of instability and immunogenicity, common to peptide-based drugs.…”
Section: Introductionmentioning
confidence: 99%
“…They have a partially conserved structure that defines the PLA2 fold [4]. Despite this similarity, sPLA2 exhibit a wide variety of pharmacological properties such as anticoagulant, platelet aggregation inhibiting [5], bactericidal [6], anti-HIV [7], antimalarial and antiparasitic [8], antitumor [9] and antiangiogenic effects [10].…”
Section: Introductionmentioning
confidence: 99%